<https://www.clinicaltrialsarena.com/news/roche-evrysdi-babies-sma/#webpage>
<http://schema.org/description>
"Roche has reported data from FIREFISH trial, where its Evrysdi demonstrated durable improvements in survival in infants with Type 1 SMA."
<https://www.clinicaltrialsarena.com/news/roche-evrysdi-babies-sma/>